New World TMT Ltd
2
39M
1
0.08
0.50
1
- Areas of investment
Summary
New World TMT Ltd appeared to be the Corporate Investor, which was created in 1995. The main department of described Corporate Investor is located in the Hong Kong. The venture was found in Asia in Hong Kong.
The high activity for fund was in 2018. The usual things for fund are deals in the range of 50 - 100 millions dollars. The fund is generally included in less than 2 deals every year.
Among the most popular portfolio startups of the fund, we may highlight Adagene. Among the most successful fund investment fields, there are Medical, Therapeutics. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - China.
The standard case for the fund is to invest in rounds with 5 partakers. Despite the New World TMT Ltd, startups are often financed by WuXi Healthcare Ventures, F-Prime Capital, GP Healthcare Capital. The meaningful sponsors for the fund in investment in the same round are Sequoia Capital China, King Star Capital, Gopher Asset Management.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.08
- Follow on index
- 0.50
- Investments by industry
- Biotechnology (2)
- Therapeutics (2)
- Medical (2)
- Investments by region
-
- China (2)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Adagene | 29 Jan 2016 | Biotechnology, Medical, Therapeutics | Early Stage Venture | 28M | Jiangsu, Gusu District, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.